investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanisms of Immune-mediated Tumor Cell Destruction
Thomas Sayers
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Neil Cross
Sheffield Hallam University
Sheffield, United Kingdom
Hideo Yagita
Juntendo University
Tokyo, Japan
Thomas Sayers
National Cancer Institute (NIH)
Rockville, United States
Related projects
Ritu Aneja
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
Breast
Matthew Davis
Classification and functional annotation of endogenous siRNAs and other small RNAs
Breast
Munira Basrai
Molecular Determinants of Chromosome Transmission and Cell Cycle Regulation
Breast
Rachelle W Johnson
Characterization of breast cancer dormancy in bone
Breast
Gregory J Hannon
Cold Spring Harbor Laboratory Cancer Research Center
Breast
Ana Soto
Mechanism of developmental toxicity of Bisphenol-A
Breast
Pathology
Fabio Petrocca
Noxa-mediated mechanisms of proteasome addiction in basal-like breast cancer
Breast
Powel Brown
A MULTICENTER PHASE II STUDY OF DOCOSAHEXAENOIC ACID IN PATIENTS WITH A HISTORY OF BREAST CANCER, PREMALIGNANT LESIONS, OR BENIGN BREAST DISEASE
Breast
Robert A Gatenby
Application of Evolutionary Principles to Maintain Cancer Control (PQ21)
Breast